Effectiveness of Cord blood as a Strategy to rule out Conjugated Hyperbilirubinemia

Miray Kurtca1, Sanjiv Harpavat2, Sridevi Devaraj1

  • 1Department of Pathology and Immunology, Baylor College of Medicine Texas Children's Hospital, Houston, TX, USA.

EJIFCC
|May 6, 2024
PubMed

Insights

Cord blood bilirubin analysis shows promise for early biliary atresia detection in newborns. This method could replace heel stick tests, benefiting low birth weight infants and facilitating timely treatment.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Biochemistry

Background:

  • Biliary atresia diagnosis requires early detection of elevated conjugated bilirubin.
  • Current screening methods necessitate a separate infant blood test, posing a challenge.
  • Newborns with biliary atresia present with high conjugated bilirubin levels at birth.

Purpose of the Study:

  • To evaluate cord blood gas analysis for assessing conjugated bilirubin levels.
  • To determine if cord blood bilirubin measurements can serve as a viable screening tool.
  • To explore an alternative to repeat heel stick tests for infant screening.

Main Methods:

  • Analysis of conjugated bilirubin levels in cord blood samples.
  • Comparison of cord blood bilirubin levels with heel stick test results.
  • Investigation of cord blood testing as a replacement for repeat heel sticks.

Main Results:

  • Elevated cord blood bilirubin levels were observed in infants with high heel stick levels.
  • Cord blood testing demonstrated potential to replace repeat heel stick tests.
  • This approach offers particular benefits for low birth weight infants.

Conclusions:

  • Cord blood bilirubin measurement is a potential novel method for early biliary atresia screening.
  • This approach may streamline the diagnostic process and improve infant outcomes.
  • Further research with larger cohorts is needed to validate this screening strategy.